Back to Search Start Over

Static magnetic fields increase cardiomyocyte differentiation of Flk-1+ cells derived from mouse embryonic stem cells via Ca2+ influx and ROS production

Authors :
Maria Wartenberg
Mohamed M. Bekhite
Heinrich Sauer
Hans-Reiner Figulla
Source :
International journal of cardiology. 167(3)
Publication Year :
2011

Abstract

Aims To investigate the effects of static magnetic fields (MFs) on cardiomyogenesis of mouse embryonic stem (ES) cell-derived embryoid bodies and Flk-1 + cardiac progenitor cells and to assess the impact of cytosolic calcium [Ca 2+ ] c and reactive oxygen species (ROS). Methods and results Embryoid bodies and ES cell-derived Flk-1 + cardiovascular progenitor cells were exposed to static MFs. The expression of cardiac genes was evaluated by RT-PCR; sarcomeric structures were assessed by immunohistochemistry; intracellular ROS and [Ca 2+ ] c of ES cells were examined by H 2 DCF-DA- and fluo-4-based microfluorometry. Treatment of embryoid bodies with MFs dose-dependent increased the number of contracting foci and cardiac areas as well as mRNA expression of the cardiac genes MLC2a, MLC2v, α-MHC and β-MHC. In Flk-1 + cells MFs (1mT) elevated both [Ca 2+ ] c and ROS, increased expression of the cardiogenic transcription factors Nkx-2.5 and GATA-4 as well as cardiac genes. This effect was due to Ca 2+ influx, since extracellular Ca 2+ chelation abrogated ROS production and MF-induced cardiomyogenesis. Furthermore absence of extracellular calcium impaired sarcomere structures. Neither the phospholipase C inhibitor U73122 nor thapsigargin inhibited MF-induced increase in [Ca 2+ ] c excluding involvement of intracellular calcium stores. ROS were generated through NAD(P)H oxidase, since NOX-4 but not NOX-1 and NOX-2 mRNA was upregulated upon MF exposure. Ablation of NOX-4 by sh-RNA and treatment with the NAD(P)H oxidase inhibitor diphenylen iodonium (DPI) totally abolished MF-induced cardiomyogenesis. Conclusion The ability of static MFs to enhance cardiomyocyte differentiation of ES cells allows high throughput generation of cardiomyocytes without pharmacological or genetic modification.

Details

ISSN :
18741754
Volume :
167
Issue :
3
Database :
OpenAIRE
Journal :
International journal of cardiology
Accession number :
edsair.doi.dedup.....31a6ee9bdf02f749452861b0a85a0dc5